Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,346.00
Bid: 12,376.00
Ask: 12,380.00
Change: 156.00 (1.28%)
Spread: 4.00 (0.032%)
Open: 12,304.00
High: 12,380.00
Low: 12,088.00
Prev. Close: 12,190.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Promising Start Amid Blue-Chip Exec Changes

Fri, 22nd Nov 2019 08:52

(Alliance News) - Stocks in London were broadly higher early Friday, after China said it wants a trade deal with US, though it did not shy away from fighting talk, and Land Securities and Rightmove both announced key executive changes.

The FTSE 100 index of London large-cap stocks was 59.31 points higher, or 0.8%, at 7,297.86 on Friday morning. The mid-cap FTSE 250 was 15.20 points up, or 0.1%, at 20,385.06, but the AIM All-Share was 0.2% higher at 904.07.

The Cboe UK 100 index was 1.0% higher at 12,383.68. The Cboe UK 250 was 0.5% up early on Friday at 18,354.37, but the Cboe UK Small Companies was marginally lower at 11,272.21.

Property developer Land Securities was 0.6% higher after it said Mark Allan will join as chief executive after leaving his role as CEO of St Modwen Properties in May next year. Allan was formerly was the CEO of student accommodation provider Unite Group between 2006 and 2016, Landsec noted.

He is to join the FTSE 100 firm "no later than June 1, 2020", Landsec added.

St Modwen, down 1.5%, making it one of the worst FTSE 250 performers, said it was "disappointed" to lose Allan but has begun the process to replace him.

Also making a key executive change was real estate firm Rightmove, up 1.0% in early dealings, naming Andrew Fisher as non-executive chair with effect on January 1. He is currently a non-executive director at retailer Marks & Spencer and insurance comparison site Moneysupermarket.com, and was formerly executive chair at music recognition mobile app Shazam.

FTSE 250 gambling software firm Playtech was down 1.8% early on Friday after it warned adjusted earnings before interest, tax, depreciation and amortisation will be "a little below consensus" in 2019.

The company, which provides betting terminals for the likes of Labrokes and Paddy Power, said: "Following a positive start to the second half, trading conditions in TradeTech have been highly challenging during September and October."

However, Playtech said trading in its Core B2B Gambling and Snaitech arms "continues to exceed management expectations, while trading in Asia has remained stable". Revenue in Regulated B2B Gambling was up 12% on a year before in the four months from July to October.

Also issuing a full-year earnings warning was Coats Group, down 11% and languishing at the foot of the FTSE 250 index.

On the back of a "slower sales performance", the industrial threads maker is now guiding for adjusted operating profit between USD196 million and USD201 million.

Adjusted operating profit in 2018 came in at USD195 million.

Elsewhere on the London Main Market, investment manager Brooks Macdonald said it will part with up to GBP39 million in cash to acquire Edinburgh-based Cornelian Asset Managers.

Brooks said: "The total net consideration is expected to be up to GBP39 million, with initial consideration being GBP31 million, of which GBP22 million will be paid in cash and GBP9m in Brooks Macdonald shares."

Brooks will launch a share placing to raise GBP30 million. The firm will price its shares at 1,775 pence apiece. The stock was down 1.9% at 1,790.0 pence each.

Pharma giant AstraZeneca edged 1.0% higher following Thursday's late news that its drug Calquence had been approved in the US for adults patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma.

The approval by the US Food & Drug Administration results from positive analyses from two phase 3 clinical trials, Elevate-TN in patients with previously untreated CLL and Ascend in patients with relapsed or refractory CLL.

In European equities, the CAC 40 index in Paris was up 0.6% and the DAX 30 in Frankfurt also 0.6% higher.

Stocks in the US ended in the red on Thursday. The S&P 500, the Dow Jones Industrial Average and Nasdaq Composite all closed 0.2% lower.

Stocks in Asia were mixed on Friday, the Nikkei 225 closed 0.3% higher in Tokyo, with Hong Kong's Hang Seng 0.5% higher in late trade. The Shanghai Composite closed 0.6% lower in China.

"Global markets remained focused on US-China trade negotiations, taking a modicum of comfort on reports that Chinese VP Liu has invited US Trade Rep Lighthizer to Beijing for further talks," Lloyds bank research said.

On Friday, President Xi Jinping said China wanted to hammer out a deal but was "not afraid" to fight back when necessary. He told former US officials and other foreign dignitaries at a meeting in Beijing that he wanted to "work for a phase-one agreement on the basis of mutual respect and equality".

The remarks came two days after Donald Trump complained Beijing had not made sufficient concessions so far, making him reluctant to conclude a bargain.

Mining stocks in London received a slight uptick following the latest trade war developments.

Antofagasta topped the blue-chip index, rising 2.5% early on Friday. Glencore was just behind, 2.4% higher, with BHP and Rio Tinto both up 1.7%.

A slew of flash PMI readings will provide some distraction from the trade tit-for-tat, with manufacturing and services numbers from Japan, Germany, the eurozone, the UK and the US.

In Japan, the Jibun Bank flash composite PMI registered a slight rise in November but pointed to a "strongly possibility" the country's economy will contract in the fourth quarter.

The flash composite purchasing manager's index read 49.9 in November, up from October's actual figure of 49.1. The flash manufacturing PMI showed a slight rise to 48.6 in November from 48.4 the previous month, while the flash services PMI indicated a rise into expansionary territory, increasing to 50.4 from 49.7.

In Germany, the flash composite PMI was 49.2 in November, up from 48.9 in October. The manufacturing PMI improved, but services slipped a bit.

The eurozone reading is due at 0900 GMT, before the UK reading at 0930 GMT.

"We look for a small decline in the November manufacturing PMI to 49.0, but a rise in the services PMI to 50.5. These numbers remain consistent with flat or slightly negative quarterly growth," Lloyds said, ahead of the UK print.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
13 Nov 2023 09:45

LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Nov 2023 15:02

London close: Stocks gain as investors await Powell speech

(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.

Read more
9 Nov 2023 12:06

LONDON MARKET MIDDAY: FTSE up despite higher for longer US rates fear

(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.

Read more
9 Nov 2023 11:02

Lancashire Holdings declares special dividend after strong year so far

(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.

Read more
9 Nov 2023 09:23

TOP NEWS: AstraZeneca ups guidance; inks licence deal for obesity drug

(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu.

Read more
9 Nov 2023 08:57

LONDON MARKET OPEN: FTSE 100 kicks off day with cautious gain

(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade.

Read more
9 Nov 2023 07:48

LONDON BRIEFING: AstraZeneca ups outlook but S4 Capital cuts

(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood.

Read more
9 Nov 2023 07:18

AstraZeneca hikes guidance after strong third quarter

(Sharecast News) - AstraZeneca released its financial results for the third quarter and first nine months of 2023 on Thursday, hiking its full-year guidance on the back of a robust performance and momentum in several segments.

Read more
3 Nov 2023 17:06

AstraZeneca plans next phase of trial on kidney drug combination data

(Alliance News) - AstraZeneca PLC on Friday touted results from a Phase IIb trial, which showed that a zibotentan and dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria.

Read more
3 Nov 2023 11:34

AstraZeneca's Lokelma lets kidney disease patients maintain therapy

(Alliance News) - AstraZeneca PLC on Thursday celebrated results from an observational study, which showed that treating hyperkalaemia with the potassium binder, Lokelma, allows chronic kidney disease and heart failure patients to maintain RAASi therapy.

Read more
2 Nov 2023 15:57

UK earnings, trading statements calendar - next 7 days

Friday 3 November 
no events scheduled 
Monday 6 November 
Kingspan Group PLCTrading Statement
Kosmos Energy LtdQ3 Results
Ryanair Holdings PLCHalf Year Results
Tuesday 7 November 
Associated British Foods PLCFull Year Results
Beazley PLCQ3 Results
Direct Line Insurance Group PLCTrading Statement
dotdigital Group PLCFull Year Results
IWG PLCQ3 Results
Persimmon PLCTrading Statement
RS Group PLCHalf Year Results
Vaalco Energy IncQ3 Results
Watches of Switzerland Group PLCTrading Statement
Wednesday 8 November 
Conduit Holdings LtdQ3 Results
ITV PLCTrading Statement
JD Wetherspoon PLCQ1 Results
Marks & Spencer Group PLCHalf Year Results
MaxCyte IncQ3 Results
Secure Trust Bank PLCTrading Statement
Smiths News PLCFull Year Results
Time Out Group PLCFull Year Results
Thursday 9 November 
3i Group PLCHalf Year Results
Apax Global Alpha LtdQ3 Results
AstraZeneca PLCQ3 Results
Auto Trader Group PLCHalf Year Results
B&M European Value Retail SAHalf Year Results
Domino's Pizza Group PLCTrading Statement
Endeavour Mining PLCQ3 Results
Flutter Entertainment PLCTrading Statement
IMI PLCTrading Statement
Indivior PLCQ3 Results
John Wood Group PLCTrading Statement
Lancashire Holdings LtdTrading Statement
National Grid PLCHalf Year Results
Regional REIT LtdTrading Statement
Renewi PLCHalf Year Results
S4 Capital PLCTrading Statement
Tate & Lyle PLCHalf Year Results
Taylor Wimpey PLCTrading Statement
TBC Bank Group PLCQ3 Results
TheWorks.co.uk PLCTrading Statement
Trakm8 Holdings PLCHalf Year Results
Urban Logistics REIT PLCHalf Year Results
Vistry Group PLCTrading Statement
WH Smith PLCFull Year Results
Wincanton PLCHalf Year Results
Wizz Air Holdings PLCHalf Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
1 Nov 2023 08:59

AstraZeneca launches collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis.

Read more
1 Nov 2023 07:33

AstraZeneca invests $220m in French gene-editing group Cellectis

(Sharecast News) - AstraZeneca is to invest in French biopharma group Cellectis to use its gene-editing technologies to develop next-gen therapeutics in areas like oncology, immunology and rare diseases.

Read more
30 Oct 2023 09:40

LONDON BROKER RATINGS: Jefferies cuts NatWest to underperform from buy

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
25 Oct 2023 11:04

PRESS: Soriot commits to five more years as AstraZeneca CEO - Times

(Alliance News) - Pascal Soriot has committed to remaining as chief executive officer of AstraZeneca PLC for another five years, The Times reported on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.